Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

Selective androgen receptor modulator

DRUG CLASS:

Selective androgen receptor modulator

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

AR positive + ER positive	HER2 Negative Breast Cancer	AR positive + ER positive	HER2 Negative Breast Cancer	enobosarm Sensitive: B - Late Trials enobosarm Sensitive : B	enobosarm Sensitive: B - Late Trials enobosarm Sensitive : B
AR positive	Estrogen Receptor Positive Breast Cancer	AR positive	Estrogen Receptor Positive Breast Cancer	enobosarm Sensitive: C2 – Inclusion Criteria enobosarm Sensitive : C2	enobosarm Sensitive: C2 – Inclusion Criteria enobosarm Sensitive : C2
ER positive	HER2 Negative Breast Cancer	ER positive	HER2 Negative Breast Cancer	enobosarm Sensitive: C3 – Early Trials enobosarm Sensitive : C3	enobosarm Sensitive: C3 – Early Trials enobosarm Sensitive : C3
ER mutation	Estrogen Receptor Positive Breast Cancer	ER mutation	Estrogen Receptor Positive Breast Cancer	enobosarm Sensitive: C3 – Early Trials enobosarm Sensitive : C3	enobosarm Sensitive: C3 – Early Trials enobosarm Sensitive : C3
ER positive	HER2 Negative Breast Cancer	ER positive	HER2 Negative Breast Cancer	EP0062 Sensitive: C3 – Early Trials EP0062 Sensitive : C3	EP0062 Sensitive: C3 – Early Trials EP0062 Sensitive : C3
AR overexpression	Estrogen Receptor Positive Breast Cancer	AR overexpression	Estrogen Receptor Positive Breast Cancer	EP0062 Sensitive: D – Preclinical EP0062 Sensitive : D	EP0062 Sensitive: D – Preclinical EP0062 Sensitive : D